Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014 (2014), Article ID 745419, 12 pages
http://dx.doi.org/10.1155/2014/745419
Research Article

Evaluation of Hypoglycemic Efficacy of Tangningtongluo Formula, a Traditional Chinese Miao Medicine, in Two Rodent Animal Models

1Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Ministry of Education, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China
2Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, China
3Pharmaceutical College, Harbin University of Commerce, Harbin, Heilongjiang 150076, China
4Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, China

Received 1 July 2014; Revised 4 September 2014; Accepted 30 October 2014; Published 5 November 2014

Academic Editor: Toshiyasu Sasaoka

Copyright © 2014 Long Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, http://www.who.int/diabetes/action_online/basics/zh/index3.html.
  2. M. Marcovecchio, A. Mohn, and F. Chiarelli, “Type 2 diabetes mellitus in children and adolescents,” Journal of Endocrinological Investigation, vol. 28, no. 9, pp. 853–863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. N. Chan, V. Malik, W. Jia et al., “Diabetes in Asia: epidemiology, risk factors, and pathophysiology,” Journal of the American Medical Association, vol. 301, no. 20, pp. 2129–2140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. R. Saltiel and C. R. Kahn, “Insulin signalling and the regulation of glucose and lipid metabolism,” Nature, vol. 414, no. 6865, pp. 799–806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Xie, Y. Zhao, and Y. Zhang, “Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 726723, 13 pages, 2011. View at Publisher · View at Google Scholar
  7. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. International Diabetes Federation, http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures.
  9. American Diabetes Association, “Economic costs of diabetes in the U.S. in 2007,” Diabetes Care, vol. 31, no. 3, pp. 3596–3615, 2008. View at Publisher · View at Google Scholar
  10. American Diabetes Association, “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012. View at Google Scholar
  11. Z. Wang, J. Wang, and P. Chan, “Treating type 2 diabetes mellitus with traditional chinese and indian medicinal herbs,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 343594, 17 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Maggie, “Traditional Chinese medicine in the treatment of diabetes,” Diabetes Spectrum, vol. 14, no. 3, pp. 154–159, 2001. View at Google Scholar
  13. L. Cheng, G.-F. Pan, X.-B. Sun, Y.-X. Huang, Y.-S. Peng, and L.-Y. Zhou, “Evaluation of anxiolytic-like effect of aqueous extract of asparagus stem in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 587260, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. V. E. Tyler, “Herbal medicine: from the past to the future,” Public Health Nutrition, vol. 3, no. 4, pp. 447–452, 2000. View at Google Scholar · View at Scopus
  15. M. J. Reed, K. Meszaros, L. J. Entes et al., “A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat,” Metabolism: Clinical and Experimental, vol. 49, no. 11, pp. 1390–1394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. F. L. Zhang, C. Ye, G. Li et al., “The rat model of type 2 diabetic mellitus and its glycometabolism characters,” Experimental Animals, vol. 52, no. 5, pp. 401–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Chen, O. Charlat, L. A. Tartaglia et al., “Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice,” Cell, vol. 84, no. 3, pp. 491–495, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Kaku, M. Province, and M. A. Permutt, “Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control,” Diabetologia, vol. 32, no. 9, pp. 636–643, 1989. View at Google Scholar · View at Scopus
  19. H. Kodama, M. Fujita, and I. Yamaguchi, “Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice,” Diabetologia, vol. 37, no. 8, pp. 739–744, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. UNESCO, http://portal.unesco.org/en/ev.php-URL_ID=28188&URL_DO=DO_TOPIC&URL_SECTION=201.html.
  21. P. S. Sona, “Nanoparticulate drug delivery systems for the treatment of diabetes,” Digest Journal of Nanomaterials and Biostructures, vol. 5, no. 2, pp. 411–418, 2010. View at Google Scholar · View at Scopus
  22. A.-G. Meng and L.-L. Jiang, “Induction of G2/M arrest by pseudolaric acid B is mediated by activation of the ATM signaling pathway,” Acta Pharmacologica Sinica, vol. 30, no. 4, pp. 442–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. WHO, WHO Monographs on Selected Medicinal Plants, vol. 1, WHO, Geneva, Switzerland, 1999.
  24. W.-Y. Jiang, “Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science,” Trends in Pharmacological Sciences, vol. 26, no. 11, pp. 558–563, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Yuan and Y. Lin, “Traditional Chinese medicinean approach to scientific proof and clinical validation,” Pharmacology and Therapeutics, vol. 86, no. 2, pp. 191–198, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. National Center for Complementary and Alternative Medicine, http://nccam.nih.gov/health/whatiscam/chinesemed.htm.
  27. WHO, “Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia,” (Report of a WHO/IDF Consultation), http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf.
  28. M. Motshakeri, M. Ebrahimi, Y. M. Goh, H. H. Othman, M. Hair-Bejo, and S. Mohamed, “Effects of brown seaweed (Sargassum polycystum) extracts on kidney, liver, and pancreas of type 2 diabetic rat model,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 379407, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus